NCT05944237 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID	NCT05944237
Title	HTL0039732 in Participants With Advanced Solid Tumours
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Cancer Research UK
Indications	malignant pheochromocytoma sarcoma malignant mesothelioma pancreatic cancer pheochromocytoma clear cell renal cell carcinoma gastroesophageal cancer cervical cancer Advanced Solid Tumor prostate cancer lung cancer castration-resistant prostate carcinoma urinary bladder cancer gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma gastric adenocarcinoma kidney cancer colorectal cancer
Therapies	Atezolizumab + HTL0039732 HTL0039732
Age Groups:	adult \| senior
Covered Countries	GBR

Additional content available in CKB BOOST